GlucoClear ICU Study

NCT02238041 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-10-01

No results posted yet for this study

Summary

The primary purpose of this Study is evaluation of the safety and accuracy of the GlucoClear CGM System.

Conditions

  • Intensive Care Unit Blood Glucose Monitoring

Interventions

DEVICE

GlucoClear System

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02238041 on ClinicalTrials.gov